Atlas Trials

Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients

Clinical trial NCT03844555 · COMPLETED

Trial details

NCT number
NCT03844555
Sponsor
Genfit
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal ImpairmentRenal InsufficiencyKidney DiseasesPharmacokinetics
Start date
2019-02-28
Primary completion
2020-03-15
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.